PR Newswire

• Business
• PR Newswire

Monport Treats Creators to Spooktacular Halloween Deals on Laser Engraving Machines

rvrisingnetwork October 18, 2025 0

NEW YORK, Oct. 17, 2025 /PRNewswire/ — As the Halloween season approaches, creators and small manufacturers are...

Read More Read more about Monport Treats Creators to Spooktacular Halloween Deals on Laser Engraving Machines

• Business
• PR Newswire

Tomorrowland 2025: Overcoming Adversity with Unity

rvrisingnetwork October 18, 2025 0

In 2025, that spirit was truly tested. Just days before opening, an unexpected fire severely damaged the...

Read More Read more about Tomorrowland 2025: Overcoming Adversity with Unity

• Business
• PR Newswire

Duchenne Muscular Dystrophy Therapeutics Market Surges Toward $6.6B by 2033 as Gene and RNA Therapies Redefine Treatment Paradigm

rvrisingnetwork October 18, 2025 0

AUSTIN, Texas and TOKYO, Oct. 17, 2025 /PRNewswire/ — The GlobalDuchenne Muscular Dystrophy (DMD) Therapeutics Market Size was...

Read More Read more about Duchenne Muscular Dystrophy Therapeutics Market Surges Toward $6.6B by 2033 as Gene and RNA Therapies Redefine Treatment Paradigm

• Business
• PR Newswire

Kelun-Biotech’s Core product Trastuzumab Botidotin Approved for Marketing by NMPA for HER2-positive BC

rvrisingnetwork October 18, 2025 0

CHENGDU, China, Oct. 17, 2025 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the “Company”) announced that the Company’s human epidermal growth factor...

Read More Read more about Kelun-Biotech’s Core product Trastuzumab Botidotin Approved for Marketing by NMPA for HER2-positive BC

• Business
• PR Newswire

Laminated Glass Market worth $54.50 billion by 2030

rvrisingnetwork October 18, 2025 0

DELRAY BEACH, Fla., Oct. 17, 2025 /PRNewswire/ — The report ‘Laminated Glass Market by Glass Type (Heat-strengthened,...

Read More Read more about Laminated Glass Market worth $54.50 billion by 2030

• Lifestyle
• PR Newswire

Wired Magazine Founding Editor Kevin Kelly Visits Rokid Headquarters, Exploring the Future of AR and AI

rvrisingnetwork October 18, 2025 0

HANGZHOU, China, Oct. 17, 2025 /PRNewswire/ — Kevin Kelly, founding executive editor of Wired magazine, visited Rokid...

Read More Read more about Wired Magazine Founding Editor Kevin Kelly Visits Rokid Headquarters, Exploring the Future of AR and AI

• Business
• PR Newswire

SCG announces presentation of clinical results of SCG142 in patients with HPV-related carcinoma at ESMO 2025

rvrisingnetwork October 18, 2025 0

SINGAPORE, Oct. 18, 2025 /PRNewswire/ — SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company developing...

Read More Read more about SCG announces presentation of clinical results of SCG142 in patients with HPV-related carcinoma at ESMO 2025

• Business
• PR Newswire

New Coaching Program by Transformation Unlimited Guides Ambitious Millennial Professionals from Chaos to Clarity

rvrisingnetwork October 18, 2025 0

JUPITER ISLAND, Fla., Oct. 17, 2025 /PRNewswire/ — Burnout, mental clutter, and life chaos have become defining...

Read More Read more about New Coaching Program by Transformation Unlimited Guides Ambitious Millennial Professionals from Chaos to Clarity

• Business
• PR Newswire

GRAIL PATHFINDER 2 Results Show Galleri ® Multi-Cancer Early Detection Blood Test Increased Cancer Detection More Than Seven-Fold When Added to USPSTF A and B Recommended Screenings

rvrisingnetwork October 18, 2025 0

PATHFINDER 2 evaluated the safety and performance of the Galleri® multi-cancer early detection (MCED) test when used alongside...

Read More Read more about GRAIL PATHFINDER 2 Results Show Galleri ® Multi-Cancer Early Detection Blood Test Increased Cancer Detection More Than Seven-Fold When Added to USPSTF A and B Recommended Screenings

• Business
• PR Newswire

Nuvalent Presents Preliminary Data for Neladalkib in Advanced ALK-positive Solid Tumors Beyond NSCLC at ESMO 2025

rvrisingnetwork October 18, 2025 0

Encouraging preliminary activity observed across diverse set of advanced ALK-positive solid tumors Global enrollment ongoing for adult...

Read More Read more about Nuvalent Presents Preliminary Data for Neladalkib in Advanced ALK-positive Solid Tumors Beyond NSCLC at ESMO 2025